ADPT - Adaptive Biotechnologies raises 2025 MRD revenue guidance to $200M as clinical volume accelerates
2025-08-06 02:14:06 ET
More on Adaptive Biotechnologies
- Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
- Adaptive Biotechnologies GAAP EPS of -$0.17 beats by $0.07, revenue of $58.88M beats by $9.48M
- Seeking Alpha’s Quant Rating on Adaptive Biotechnologies
- Historical earnings data for Adaptive Biotechnologies
- Financial information for Adaptive Biotechnologies